Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
This Bitcoin-focused microcap is building a treasury strategy centered on accumulating BTC (click to learn more) Sego Intersects 100 M of 0.626 gpt Gold, Including 24.37 M of 0.958 gpt Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Genix Pharmaceuticals Corp GENPF


Primary Symbol: V.GENX

Healthcare Industrials Drug Manufacturers - Specialty & Generic Business Services
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops. It also provides Flu-X, an anti... see more

Current News (TSXV:GENX)

Genix Pharmaceuticals Issues Clarification to Previously Announced Private Placement Terms

Newsfile October 7, 2025

Genix Pharmaceuticals Closes Private Placement

Newsfile September 4, 2025

Genix Announces TSX-V Approval of Warrant Amendments

Newsfile February 6, 2024

Genix Announces Warrant Repricing and Seeks Extension

Newsfile January 18, 2024

Genix Announces AGM Results

Newsfile May 26, 2023

Genix Receives Approval to Extend Warrants from the TSX Venture Exchange

Newsfile July 28, 2022

Genix Proposes to Extend Warrants

Newsfile July 20, 2022

Genix Pharmaceuticals Corp. Receives Approval for Drug Establishment License

Newsfile July 15, 2021

Genix Pharmaceuticals Corp. Lists on the OTCQB Venture Market Exchange

Newsfile June 21, 2021
View More News ››

Opinion & Analysis (TSXV:GENX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:GENX)

RE:RE:RE:Coule be a game changer Whitehorse hc approval!

HC = healt Canada 
Sonboss - July 15, 2020

RE:RE:Coule be a game changer Whitehorse hc approval!

Only mistake! Autocorrect on my cell phone 
Sonboss - July 15, 2020

RE:Coule be a game changer Whitehorse hc approval!

Mr sonboss, what is whitehorse HC approval? what does that mean please, im a simple guy, thankyou north40!
north40 - July 15, 2020

RE:Coule be a game changer Whitehorse hc approval!

Could be a game changer with hc approval * autocorect 
Sonboss - July 14, 2020

Coule be a game changer Whitehorse hc approval!

Genix Pharmaceuticals Corporation Enters into a Definitive Agreement to Acquire Global Rights to Flu-X(R) https://finance.yahoo.com/news...
Sonboss - July 14, 2020

RE:Head office

1055 W. Hastings is an office building downtown Vancouver. Not an apartment building.
southbeach1 - July 14, 2020
View more Bullboard ››

Blue Sky Uranium Corp.

Blue Sky Uranium Corp.

Blue Sky Uranium Corp., a junior uranium exploration company, engages in the acquisition, exploration, and evaluation of ...
View More »

Podcasts